Trelegy Ellipta – Compliance Alert

Lower Risk

This ad is within acceptable compliance thresholds.

Analysis of this 60s ad identified 2 enforcement patterns, primarily Visual Distraction. Patterns span Visual Distraction — “Family & Social Scenes” identified at 44.6s, previously cited in Jardiance (x3), Contrave, Qulipta.

Video Timeline

Risk disclosure: 31.4s – 55.7s (24.2s of 60.1s total — 40.3% of ad)

Risk Window

0s15s30s45s60s

Daily Activities?Family & Social?Risk Window?

Patterns Detected (2)

Each pattern below is a known FDA enforcement concern, identified by matching this ad against 14 violation types from 34 FDA warning letters

Pattern	Dimension	Score	Evidence	CFR
Family & Social Scenes Warm family scenes that emotionally minimize risk information	Visual Distraction	68	1 clip	21 CFR 202.1(e)(1)	▶
FDA Concern: Risk information must be presented in a clear, conspicuous, and neutral manner without distracting visuals Previously cited: Jardiance (x3), Contrave, Qulipta, Calquence, Austedo (x2)
Daily Activities Relatable lifestyle visuals that divert attention from safety disclosures	Visual Distraction	68	1 clip	21 CFR 202.1(e)(1)	▶
FDA Concern: Risk information must be presented in a clear, conspicuous, and neutral manner without distracting visuals Previously cited: Contrave, Velsipity, Qulipta, Fasenra (salsa)

Compliance Alert: Trelegy Ellipta

Recommendations